Cellestia Biotech AG
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Study of CB-103 in Adult Patients With Advanced or Metastatic Solid Tumours and Haematological Malignancies (NCT03422679) | Cellestia Biotech AG | 2017-12-05 |
Track Cellestia Biotech AG automatically
Every clearance here is in the API, with alerts when new ones post.